Get Plus

Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

Israel HayomHealth

Israeli Researchers Develop Novel Blood Test for Dangerous Heart Disease

Translated & summarized from Israel Hayom by baba

Center-rightNeutral tone

Hebrew · 1 newsroom

Researchers at Ben-Gurion University of the Negev have developed a new blood test technology for early detection of rheumatic heart disease. The smart synthetic polymer-based test is stable at room temperature, requires no refrigeration, and uses basic equipment, making it accessible for remote areas. The adaptable technology can also be modified to detect other biological markers for various diseases.

The story in 5 lines · by baba

  • Ben-Gurion University researchers created a new blood test for early detection of rheumatic heart disease.
  • The technology uses a smart synthetic polymer, requiring no refrigeration or expensive lab equipment.
  • It can be measured with a basic spectrophotometer, making it accessible in areas with limited resources.
  • The polymer is stable at room temperature, aiding its use in regions with poor lab infrastructure.
  • The method is adaptable for detecting other biological markers and inflammatory diseases.

Researchers at Ben-Gurion University of the Negev have developed a novel blood test technology that could enable the early detection of rheumatic heart disease, a condition that can affect young people, particularly in areas with limited access to healthcare and advanced diagnostics. The technology utilizes a smart synthetic polymer, eliminating the need for refrigeration or expensive laboratory equipment, potentially making tests simpler and more accessible.

The system identifies biological markers associated with the disease by employing a synthetic material that emits light when disease markers bind to a peptide. This light can be measured with a basic spectrophotometer, bypassing the need for costly, advanced instrumentation. Furthermore, the polymer's stability at room temperature is a significant advantage for use in regions with limited laboratory infrastructure.

The researchers noted that the method can be adapted to detect other biological markers by changing the peptide. Markers such as ICAM-1, VCAM-1, and E-selectin, which are linked to inflammatory processes, can be identified using this approach. This adaptability suggests potential future applications for diagnosing and studying other inflammatory diseases.

Ilana Tavor, a research student, presented the findings at the ILAF 2026 conference, where her work received an "Outstanding Poster" award among approximately 1,100 presented works. The research was supported by the Leducq Foundation as part of the PRIMA consortium, which includes researchers and institutions from the United States, Israel, Brazil, Tanzania, Uganda, India, Nepal, and Canada. Professor Robert A. Levine from Massachusetts General Hospital and Harvard University, who has since passed away, was also involved in the study.

Israel HayomRight · Tel Aviv

Sign in to baba News

Sign in to follow newsrooms, topics and people.

or use an email code

HealthTopic

Sign in to baba News

Sign in to follow newsrooms, topics and people.

or use an email code

Mentioned

Related stories · 1

Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.

Open the Wire